Biochemical basis for the extreme sensitivity of Turkeys to aflatoxin B1

Toxicology and Applied Pharmacology

Volumn 165, Issue 1, 2000, Pages 45-52

  Klein, Patrick J ^a   Buckner, Robert ^a   Kelly, Jack ^a   Coulombe Jr , Roger A ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; LIVER CYTOSOL; MYCOTOXICOSIS; NEWBORN; NONHUMAN; TOXICITY TESTING; TOXIN ANALYSIS; TURKEY (BIRD);

ANIMALIA; AVES; MAMMALIA; MELEAGRIS GALLOPAVO;

EID: 0034658003     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8926     Document Type: Article

References (55)

1. Allcroft R., Carnaghan R. B. A. Toxic products in groundnuts: Biological effects. Chem. Ind. 2:1963.
2. 1. Proc. Natl. Acad. Sci. USA. 87:1990;4790-4793.
3. 1 in mammalian airway epithelium. Carcinogenesis (Lond.). 12:1991;305-310.
4. Benson A. M., Hunkeler M. J., Talalay P. Increase of NAD(P)H: quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA. 77:1980;5216-5220.
5. Bradford M. M. A rapid and sensitive method for quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Broderick G. A., Clayton M. K. Rumen protein degradation rates estimated by non-linear regression analysis of Michaelis-Menten in vitro data. Br. J. Nutr. 67:1992;27-42.
7. Buetler T. M., Eaton D. L. cDNA cloning, mRNA expression and induction of alpha-class glutathione S-transferases in mouse tissues. Cancer Res. 52:1992;314-318.
8. Busby W. F., Wogan G. N. Aflatoxins. Searle C. E. Chemical Carcinogens. 1984;945-1136 American Chemical Society, Washington.
9. Carnaghan R. B., Lewis G., Patterson D. S., Allcroft R. Biochemical and pathological aspects of groundnut poisoning in chickens. Pathol. Vet. 3:1966;601-615.
10. Clapper M. L., Everly L. C., Strobel L. A., Townsend A. J., Engstrom P. F. Coordinate induction of glutathione S-transferase α, μ, and π expression in murine liver after a single administration of oltipraz. Mol. Pharmacol. 45:1993;469-474.
11. Coulombe R. A., Shelton D. W., Sinnhuber R. O., Nixon J. E. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system. Carcinogenesis (Lond.). 3:1982;1261-1264.
12. Coulombe R. A. Jr. In symposium: Biological action of mycotoxins. J. Dairy Sci. 76:1993;880-891.
13. Council for Agricultural Science and Technology, 1989, Mycotoxins: Economic and Health Risks. Report No. 116, C.A.S.T. Ames, Iowa.
14. Eaton D. L., Ramsdell H. S. Species- and diet-related differences in aflatoxin biotransformation. Bhatnagar D., Lillehoj E. B., Arora D. K. Handbook of Applied Mycology. 1992;157-182 Marcel Dekker, New York.
15. 1 defines a subfamily of aldo-keto reductases. Proc. Natl. Acad. Sci. USA. 90:1993;10350-10354.
16. Ellis E. M., Hayes J. D. Substrate specificity of an aflatoxin-metabolizing aldehyde reductase. Biochem. J. 312:1995;535-541.
17. 1 metabolism in human liver. Proc. Natl. Acad. Sci. USA. 87:1990;8306-8310.
18. 1. Cancer Res. 54:1994;101-108.
19. 1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 141:1996;595-606.
20. Giambrone J. J., Diener U. L., Davis N. D., Panangala V. S., Hoerr F. J. Effects of aflatoxin on young turkeys and broiler chickens. Poult. Sci. 64:1985;1678-1684.
21. Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 froms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261:1986;5051-5060.
22. Guengerich F. P. Oxidation of 17α ethynylestradiol by human liver cytochrome P450. Mol. Pharmacol. 33:1988;500-508.
23. 1. Mutat. Res. 402:1998;121-128.
24. Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249:1974.
25. Habig W. H., Jakoby W. B. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77:1981;398-405.
26. Halpert J. R. Multiplicity of steroid inducible cytochromes P450 in rat liver microsomes. Arch. Biochem. Biophys. 263:1988;59-68.
27. Hamilton P. B., Tung H. T., Harris J. R., Gainer J. H., Donaldson W. E. The effect of dietary fat on aflatoxicosis in turkeys. Poult. Sci. 51:1972;165-170.
28. 1-8,9-epoxide. Biochem. J. 279:1991a;385-398.
29. 1. Pharmacol. Ther. 50:1991b;443-472.
30. Hayes J. D., Judah D. J., Neal G. E., Nguyen T. Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity of aflatoxin B1-8,9-epoxide. Biochem. J. 285:1992;173-180.
31. 1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res. 53:1993;3887-3894.
32. Huff W. E., Kubena L. F., Harvey R. B., Corrier D. E., Mollenhauer H. H. Progression of aflatoxicosis in broiler chickens. Poult. Sci. 65:1986;1891-1899.
33. 1exo-8,9-epoxide catalyzed by rat and human glutathione transferases: Estimation of kinetic parameters. Biochemistry. 36:1997;3056-3060.
34. 1 is expressed in rat liver during carcinogenesis and following the administration of and antioxidant. Biochem. J. 292:1993;13-18.
35. 1 activation in human lung. Toxicol. Appl. Pharmacol. 144:1997;88-95.
36. Kubena L. F., Harvey R. B., Huff W. E., Corrier D. E., Phillips T. D., Rottinghaus G. E. Efficacy of a hydrated sodium calcium aluminocilicate to reduce the toxicity of aflatoxin and T-2 toxin. Poult. Sci. 69:1990;1078-1096.
37. Kubena L. F., Huff W. E., Harvey R. B., Yersin A. G., Elissalde M. A., Witzel D. A., Giroir L. E., Phillips T. D., Peterson H. D. Effects of a hydrated sodium calcium aluminosilicate on growing turkey poults during aflatoxicosis. Poult. Sci. 70:1991;1823-1830.
38. 1 present in Fusarium monilforme culture material and aflatoxin singly and in combination to turkey poults. Poult. Sci. 74:1995;1295-1303.
39. 1 metabolism in human hepatocytes in primary culture. Cancer Res. 55:1995;5574-5579.
40. 1 in the rat and mouse. Toxicol. Appl. Pharmacol. 90:1987;401-409.
41. 1. Toxicol. Appl. Pharmacol. 58:1981;431-437.
42. 1 with reduced glutathione, catalysed by cytosolic glutathion-S-transferaes in livers of rats, mice, and guinea pigs. Biochem. Pharmacol. 36:1987;4269-4276.
43. 1 induced hepatocidity. Biochem. Biophys. Res. Commun. 114:1983;813-821.
44. Pohl R. J., Fouts J. R. A rapid method for assaying the metabolism of 7-ethoxyresurufin by microsomal subcellular fractions. Anal. Biochem. 107:1980;150-155.
45. 1. Toxicol. Appl. Pharmacol. 105:1990;351-363.
46. 1 carcinogenesis: Comparative kinetics of microsomal biotransformation. Cancer Res. 50:1990;615-620.
47. 1-8,9-oxide by glutathione S-transferases from human and rodent liver. Toxicologist. 11:1991.
48. 1exo- and endo-epoxides by rat and human glutathione S-transferase. Chem. Res. Toxicol. 5:1992;470-478.
49. 1 8,9-exo-epoxide. Chem. Res. Toxicol. 6:1993;64-68.
50. SAS, 1985, User's Guide: Statistics, Version 5 Ed, SAS Institute, Inc. Cary, NC.
51. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. USA. 86:1989;462-465.
52. Shimada T., Yamazaki H., Mimura M., Guengerich F. P. Rat pulmonary microsomal cytochrome P-450 enzymes involved in the activation of procarcinogens. Mutat. Res. 284:1992;233-241.
53. 1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes. Carcinogenesis (Lond). 17:1996;79-87.
54. Testa B., Jenner P. Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metab. Rev. 12:1981;1-117.
55. 1-2,3-epoxide. Cancer Res. 43:1983;4752-4756.